Rapport Therapeutics, Inc. · NASDAQ:RAPP

Cormorant Asset Management, LP reported a 5.56% stake in Rapport Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Cormorant Asset Management, LP reported a 5.56% stake in Rapport Therapeutics, Inc., 2,657,521 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
5.56%
Shares
2,657,521
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Cormorant Asset Management, LP5.56%2,657,521
Bihua Chen5.56%2,657,521

Source

View original at SEC

Related